Entrada Therapeutics Inc Logo

Entrada Therapeutics Inc (TRDA): Eigentümerstruktur

Takani Score ?
18.0

Preis (11.09.2026)52W Hoch52W Tief
6,8 US Dollar16,45 US Dollar5,02 US Dollar
Analysten KonsensBuyOutperformHoldUnderperformSell
19 US Dollar22000
Externe Analystenschätzungen (Quelle: EODHD) – keine Anlageempfehlung von Takani.
#SharesShort [%]Short Ratio
38.936.6699,357,7

Eigentümerstruktur

Analyse der Aktionärsstruktur und institutionellen Investoren

Unternehmensdaten

Grundlegende Informationen

Grunddaten

Name Entrada Therapeutics Inc
Mitarbeiter 152
Handelsplatz NASDAQ
Ticker Symbol TRDA
IPO Datum 2021-10-29
Adresse One Design Center Place, Boston, MA, United States, 02210

Unternehmensführung

RangNamePosition
1Mr. Dipal DoshiCEO & Director
2Mr. Nathan J. DowdenPresident & COO
3Dr. Natarajan Sethuraman Ph.D.President of Research & Development
4Mr. Kory James Wentworth CPACFO & Treasurer
5Dr. Jared Cohen J.D., Ph.D.General Counsel
6Ms. Karla MacDonaldChief Corporate Affairs Officer
7Mr. Kevin Healy Ph.D.Senior Vice President of Regulatory Affairs
8Sandeep BasnetHead of Information Technology

Aktionärsverteilung

Aufteilung der Investoren

Größte Investoren

RangInhaberAnteileWert
1Baker Bros Advisors LP13,03%34,50 Mio. USD
25AM Venture Management, LLC10,42%27,58 Mio. USD
3BlackRock Inc6,06%16,04 Mio. USD
4Merck & Co Inc4,47%11,83 Mio. USD
5Vanguard Capital Management, LLC3,23%8,54 Mio. USD
6MPM Oncology Impact Management LP3,22%8,52 Mio. USD
7TCG Crossover Management, LLC2,72%7,21 Mio. USD
8Wellington Management Company LLP2,45%6,49 Mio. USD
9Millennium Management LLC1,96%5,20 Mio. USD
10StepStone Group LLC1,96%5,18 Mio. USD
11Geode Capital Management, LLC1,71%4,54 Mio. USD
12State Street Corp1,37%3,63 Mio. USD
13T. Rowe Price Associates, Inc.1,35%3,58 Mio. USD
14Citadel Advisors Llc1,01%2,68 Mio. USD
15Dimensional Fund Advisors, Inc.0,97%2,56 Mio. USD
16Jacobs Levy Equity Management, Inc.0,86%2,27 Mio. USD
17Acadian Asset Management LLC0,86%2,27 Mio. USD
18Northern Trust Corp0,60%1,60 Mio. USD
19Vanguard Portfolio Management, LLC0,57%1,50 Mio. USD
20Woodline Partners LP0,55%1,47 Mio. USD